Literature DB >> 20587911

Incidence rate of ovarian cancer in Iran in comparison with developed countries.

M Arab1, M Khayamzadeh, A Tehranian, M Tabatabaeefar, M Hosseini, R Anbiaee, F Golfam, M E Akbari.   

Abstract

BACKGROUND: Ovarian cancer is one of the most common gynecologic malignancies. The present study was designed to compare age-standardized incidence rate (ASR) of ovarian cancer in Iran with that in Australia and some other developed countries.
MATERIALS AND METHODS: Data from the Cancer Registry Program of Iran, as a base, were compared with the cancer registry reports of surveillance, epidemiology and end results program in the USA, considering the population of the USA in the year 2000 as the standard population.
RESULTS: In all the age groups, ASR of ovarian cancer was much lower in Iran. Overall rates of ovarian cancer in Iran and the USA were 3.9 and 16.2 per 100,000, respectively.
CONCLUSION: Age-standardized ovarian cancer rate in Iran was much lower in comparison with high incidence areas in the world. Encouraging oral contraceptive use and reduction in fat intake may be effective in decreasing the rate of ovarian cancer or keeping its rate constant in Iran.

Entities:  

Mesh:

Year:  2010        PMID: 20587911     DOI: 10.4103/0019-509X.64721

Source DB:  PubMed          Journal:  Indian J Cancer        ISSN: 0019-509X            Impact factor:   1.224


  8 in total

1.  Preparation, Characterization and Cytotoxic Effects of Pegylated Nanoliposomal Containing Carboplatin on Ovarian Cancer Cell Lines.

Authors:  Meysam Ebrahimifar; Amir Nili-Ahmadabadi; Azim Akbarzadeh; Hasan Ebrahimi Shahemabadi; Majid Hasanzadegan; Hemen Moradi-Sardareh; Hassan Madadizadeh; Jalal Rezaee-Diyan
Journal:  Indian J Clin Biochem       Date:  2016-08-02

2.  Changing trends in the incidence of ovarian neoplasia and its relationship with the risk factors: a report of 311 cases from north-eastern anatolia region.

Authors:  Elif Demirci; Ferah Tuncel Daloglu; Muhammet Calik; Eren Altun; Sare Sipal; Bunyamin Borekci
Journal:  Eurasian J Med       Date:  2014-08-26

Review 3.  Association of Combined Estrogen-Progestogen and Progestogen-Only Contraceptives with the Development of Cancer.

Authors:  William V Williams; Louise A Mitchell; S Kathleen Carlson; Kathleen M Raviele
Journal:  Linacre Q       Date:  2019-01-03

4.  Inequalities in cancer distribution in tehran; a disaggregated estimation of 2007 incidencea by 22 districts.

Authors:  Marzieh Rohani Rasaf; Rashid Ramezani; Mitra Mehrazma; Mohamad Reza Rohani Rasaf; Mohsen Asadi-Lari
Journal:  Int J Prev Med       Date:  2012-07

5.  Comparison of Age- Standard Incidence Rate Trends of Gynecologic and Breast Cancer in Iran and Other Countries.

Authors:  Maliheh Arab; Giti Noghabaei
Journal:  Iran J Public Health       Date:  2014-10       Impact factor: 1.429

6.  Expression of Vascular Endothelial Growth Factor (VEGF) and Epidermal Growth Factor Receptor (EGFR) in Patients With Serous Ovarian Carcinoma and Their Clinical Significance.

Authors:  Reza Ranjbar; Foroogh Nejatollahi; Ahmad Sina Nedaei Ahmadi; Hossein Hafezi; Akbar Safaie
Journal:  Iran J Cancer Prev       Date:  2015-08-24

7.  Differential Expression Pattern of Epithelial Mesenchymal Transition Gens: AXL, GAS6, Claudin-1, and Cofilin-1, in Different Stages of Epithelial Ovarian Cancer.

Authors:  Elham Hassani; Mahmood Shekari Khaniani; Mojtaba Saffari; Amirnader Emami Razavi; Reza Shirkoohi; Sima Mansoori Derakhshan
Journal:  Iran J Public Health       Date:  2019-09       Impact factor: 1.429

8.  Cancer trends in a province of Southwest of Iran, 2003-2016.

Authors:  Ali Ahmadi; Fatemeh Salehi; Zenab Ahmadimirghaed
Journal:  J Res Med Sci       Date:  2018-09-24       Impact factor: 1.852

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.